Concurrent (CAFT) versus sequential (CAF-T) chemohormonal therapy (cyclophosphamide, doxorubicin, 5-fluorouracil, tamoxifen) versus T alone for postmenopausal, node-positive, estrogen (ER) and/or progesterone (PgR) receptor-positive breast cancer : mature outcomes and new biologic correlates on phase III intergroup trial 0100 (SWOG-8814)
収録刊行物
-
- Proceedings of the 27th Annual Meeting of the San Antonio Breast Cancer Symposium 2004
-
Proceedings of the 27th Annual Meeting of the San Antonio Breast Cancer Symposium 2004 2004